Novel Biophotonics Methodology for Colon Cancer Screening
Completed
Conditions studied: Colon Cancer
In brief
The study is testing a new, safe and effective way for the early detection of colon cancer. The method uses Low-coherence Enhanced Backscattering Spectroscopy (LEBS). This is an optic probe which is a small device that uses light (not laser) to assess the colon lining. This probe will be used before colonoscopy to identify subjects who do and do not have precancerous changes in the colon by capturing the light reflected back from the rectal wall and that will be assessed without the need for colonoscopy and bowel preparation (colon cleaning). This device may detect early cancerous changes in colon tissue with higher accuracy than current tests.
Key facts
- Study ID
- NCT01999478
- Run by
- Boston Medical Center
- People needed
- 4000
- Starts
- 2008-02-01
- Expected to finish
- 2015-02-01
- Last updated by the study team
- 2016-06-13
Who can join
Age: 18 and older. Sex: any. Healthy volunteers: accepted.
You may qualify if…
- Patients who have appointments in the GI Clinic and are/or will be scheduled for an colonoscopy as per standard of care.
- Patients must be 18 years of age or older.
You may not qualify if…
- Patients who have a history of Inflammatory Bowel Disease.
- Patients who have colitis.
- Patients who are undergoing chemotherapy.
Where it is running
- University of Southern California — Los Angeles, California, United States
- NorthShore University HealthSystem — Evanston, Illinois, United States
- Northwestern Univeristy — Evanston, Illinois, United States
- University of Indiana — Indianapolis, Indiana, United States
- Boston Medical Center — Boston, Massachusetts, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.